Navigation Links
Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
Date:1/24/2008

Doctors Are Combining Portrait(R) Plasma with Fractionated Lasers Or in

Place of Surgery to Alleviate the Signs of Aging of the Eyes

WALTHAM, Mass., Jan. 24 /PRNewswire/ -- When it comes to the aging eye area, going under the knife is no longer the only option. According to the American Academy of Facial and Plastic Surgery, surgeons are seeing a more educated patient who is interested in non-surgical options to obtain the best results. One of the most requested aesthetic treatments is wrinkle reduction and tightening around the eyes and the excess tissue of the upper eyelid. For patients who experience sagging, droopy eye lids, wrinkles and puffiness, blepharoplasty (eyelid surgery) is no longer the only option to obtain a more youthful eye area.

One solution offered by Dr. Brian Biesman, Ophthalmic Plastic and Reconstructive Surgeon of Nashville Centre for Laser and Facial Surgery in Nashville, Tennessee, is a cosmetic combination that helps patients reap maximum benefits from their treatment; blepharoplasty, Portrait Plasma, a novel plasma skin regeneration technology, and injectables such as Botox and fillers.

"Blepharoplasty removes the excess tissue and skin, but Portrait Plasma improves skin quality. It smoothes fine lines and treats both wrinkles and sun damage, which surgery alone cannot do," according to Dr. Biesman. Additionally he indicated injectables may be used to relax the muscles and then, in some cases, filler may be used to enhance volume. Physicians are also combining Portrait with other aesthetic procedures, such as fractionated lasers, a popular treatment that does not meet patient's demands for improvement in the peri-orbital area. Richard Fitzpatrick, MD from La Jolla Cosmetic Surgery Centre combines Portrait(R) Plasma with fractional laser for further results on the face. At times he chooses Portrait Plasma for treating eyes over other devices in his practice remarking, "Eyelid skin is uniquely suited for
'/>"/>

SOURCE Rhytec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. GSK Does Not Option XL784 for Further Development
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
7. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
8. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
9. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
10. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
11. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Nov. 6 Caraco Pharmace...aunched ketorolac tromethamine ophthalmic solution... and Drug Administration (FDA) for Sun Pharma,s Ab...Acular® opthalmic solution on the first day f...olac is therapeutically equivalent to Acular®...
(Date:11/6/2009)...IS, November 6 , - Trial ...lid for the,Treatment of Multi-Resistant Staphyloc... a speciality pharmaceutical company focused on th...esigned to overcome the significant global,problem... most advanced oral,antibacterial NXL103 (floprist...
(Date:11/5/2009)...GO, Nov. 5 Althea Technologies, I...turing services for biopharmaceutical products ann...lopment to the company,s platform of services, whi...es Matsuura, Director of Formulation Development. ...ion and analytical scientists, along with new labo...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 1Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 3Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 4Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 1Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 1Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 3
...Company Planning to Initiate Phase 2 Trials in Col...Cancer in Q307 -, SOUTH SAN FRANCISCO, Calif., Jun...aceuticals, Inc. , a,biopharmaceutical company foc...s from an interim safety analysis of two Phase 1,d...ion platinum for,the potential first-line treatmen...
...ven year follow up of pivotal trial confirms that ...EL, Switzerland, June 4, 2007-A follow-up analysis...non-Hodgkin,s lymphoma,(NHL) who were treated with...) over seven years ago has revealed exciting resul...ase III study has shown,that over half (53%) of th...
Other Medicine Technology:Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 2Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 3Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 4Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 5Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 6MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 2MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 3MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 4
(Date:11/8/2009)...ewswire-USNewswire/ -- Tonight the House of Repres...erica Act, landmark health reform legislation that... affordable, stable and secure health care coverag...he insurance industry,s worst practices, would ext...eficit by $104 billion over ten years. Groups repr...
(Date:11/8/2009)...’s Health Network (MHN) urges military veter...those linked to exposure to chemicals, atomic agen...r cancer is one of those cancers that is two times...once smoked or currently smoke cigarettes. , ... 8, 2009 -- Men’s Health Network (MHN) kicke...
(Date:11/8/2009)...rk of Hispanic health advocates committed to achie...WASHINGTON, Nov. 7 "Ton... have heard the voice of America,s families by pas...ow the Senate must deliver, without delay, on the .... Jane L. Delgado, President and CEO of the Nation...
(Date:11/8/2009)...ewswire-USNewswire/ -- The following was released ... Insurrecta Nex. ,, Mr. Terry and his associat...eep child-killing by abortion out of any health ca...is a great first step to victory -- a touchdown in...g ahead of us. Our rejoicing must be tempered by r...
(Date:11/8/2009)... 8 March of Dimes hoste... to recognize prominent individuals who are celebr... models for March of Dimes commitment to improve t...s November Prematurity Awareness Month campaign, c...he fight for preemies! ,, (Photo: http://www....
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3
...arrow removal and injection of a hormone helps pro...ions in the body, it was reported by Yale School o...his could radically change the way patients are cu...ssor of orthopedics . , She said currently avail...
...shing Taste with Benefits of Noni, PROVO, Utah, F... HIRO(TM) Super Fruits Sparkling Black Currant, th...-drink noni-based beverage line. An all,natural be...ling Black Currant is the first of a new,category ...
... for,Disease Control and Prevention released resul...EMA travel trailers. On May 15, 2007, FEMA,Adminis...ee on Homeland,Security that "we have been told th...maldehyde exposure can range from,respiratory irri...
...detzki, has found a link between cell phone usage ... physician, epidemiologist and lecturer at Tel Avi...ently in the American Journal of Epidemiology, in ... Those who used a cell phone heavily on the side o...
...tion,s,largest pharmacy benefits management compan... General from 29 states resolving claims of,decept...bett said that the agreement was reached with,Care...required to significantly change,its business prac...
...e Next Before Final Version is,Voted On, BETHESDA...essions of "national need" will include occupation...oor is agreed to by the,Senate. AOTA staff worked ... floor of the House that occupational therapists,b...
Other Medicine News:Health News:Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant 2Health News:Thompson Demands Solution to Formaldehyde Trailer Crisis 2Health News:Cell phone-cancer link found by Tel Aviv University scientist 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark 3Health News:AOTA Gets Profession Addressed on House Floor in Federal Loan Repayment Bill 2
...o-Surgery provides clip appliers in 10mm and 5mm s...iers provide precise clip placement., ,The ALLPOR...e preloaded, single-trigger instruments are design... a 5mm trocar, through a 5mm reducer cap in a larg...
...P-HS assay utilizes turbidimetric immunoassay meth...uring over the range of 0.2-28.0 mg/dL. This assay...to most clinical chemistry analyzers. The Wako CRP...ecision, linearity, correlation, and sensitivity. ...
LabDAQ3 Laboratory Information System
...e for laboratories to work more efficiently has ne...e solutions. With the COBAS INTEGRA® 400 plus,...ies, robotic handling of reaction cuvettes and imp...broad menu and ease-of-use required for true workl...
Medicine Products: